Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Parkinson’s disease often starts on one side of the body, and new research shows this asymmetry influences how non-motor symptoms progress.

These findings highlight the significance of rearing behavior and behavioral lateralization as potential behavioral markers ...

If living near a golf course seems scenic and relaxing, it may also be linked to a higher risk of Parkinson’s disease, ...